Global Circulating Tumor Cells Market by Manufacturers, Countries, Type and Application, Forecast to 2023
September 2018
152
About the Report
About the Report
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Scope of the Report:
This report studies the Circulating Tumor Cells market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells market by product type and applications/end industries.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
North America is the largest supplier of CTCs Products, with a revenue market share nearly 53.18% in 2016. Europe is the second largest supplier of CTCs products, enjoying revenue market share nearly 28.01% in 2016.
Growth of the global CTCs market is mainly driven by increasing prevalence of cancer globally. Increasing prevalence of various cancers such as breast cancer, prostate cancer and lung cancer is expected to drive growth of the CTCs test market over the forecast period.
FDA approvals for various non-invasive diagnostic tests to detect cancer are set to define the regulatory landscape for CTCs tests. Companies in the CTCs market space are expected to invest more on test kits and cost containment procedures to provide innovative diagnostic solutions to the oncologists and physicians for detecting metastasis.
The global Circulating Tumor Cells market is valued at 1220 million USD in 2017 and is expected to reach 2740 million USD by the end of 2023, growing at a CAGR of 14.5% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Menarini-Silicon Biosystems
Qiagen?Adnagen?
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex Corporation
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
CTC Enrichment
CTC Detection
CTC Analysis
Market Segment by Applications, can be divided into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
Products
Companies
Menarini-Silicon Biosystems
Qiagen?Adnagen?
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex Corporation
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE
Table of Contents
Table of Contents
Table of Contents
1 Circulating Tumor Cells Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells
1.2 Classification of Circulating Tumor Cells by Types
1.2.1 Global Circulating Tumor Cells Revenue Comparison by Types (2017-2023)
1.2.2 Global Circulating Tumor Cells Revenue Market Share by Types in 2017
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cells Market by Application
1.3.1 Global Circulating Tumor Cells Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Other
1.4 Global Circulating Tumor Cells Market by Regions
1.4.1 Global Circulating Tumor Cells Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2013-2023)
1.5 Global Market Size of Circulating Tumor Cells (2013-2023)
2 Manufacturers Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Business Overview
2.1.2 Circulating Tumor Cells Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.2 Qiagen?Adnagen?
2.2.1 Business Overview
2.2.2 Circulating Tumor Cells Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qiagen?Adnagen? Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.3 Clearbridge Biomedics
2.3.1 Business Overview
2.3.2 Circulating Tumor Cells Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celsee
2.4.1 Business Overview
2.4.2 Circulating Tumor Cells Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.5 Fluidigm
2.5.1 Business Overview
2.5.2 Circulating Tumor Cells Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.6 ApoCell
2.6.1 Business Overview
2.6.2 Circulating Tumor Cells Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.7 Greiner Bio-one GmbH
2.7.1 Business Overview
2.7.2 Circulating Tumor Cells Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.8 Advanced Cell Diagnostics
2.8.1 Business Overview
2.8.2 Circulating Tumor Cells Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aviva Biosciences
2.9.1 Business Overview
2.9.2 Circulating Tumor Cells Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.10 Fluxion Biosciences
2.10.1 Business Overview
2.10.2 Circulating Tumor Cells Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sysmex Corporation
2.11.1 Business Overview
2.11.2 Circulating Tumor Cells Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.12 Epic Sciences
2.12.1 Business Overview
2.12.2 Circulating Tumor Cells Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.13 Cynvenio
2.13.1 Business Overview
2.13.2 Circulating Tumor Cells Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.14 CytoTrack
2.14.1 Business Overview
2.14.2 Circulating Tumor Cells Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ikonisys
2.15.1 Business Overview
2.15.2 Circulating Tumor Cells Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.16 Vortex BioSciences
2.16.1 Business Overview
2.16.2 Circulating Tumor Cells Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.17 Gilupi
2.17.1 Business Overview
2.17.2 Circulating Tumor Cells Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.18 Biocept
2.18.1 Business Overview
2.18.2 Circulating Tumor Cells Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.19 ScreenCell
2.19.1 Business Overview
2.19.2 Circulating Tumor Cells Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
2.20 ANGLE
2.20.1 Business Overview
2.20.2 Circulating Tumor Cells Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
3 Global Circulating Tumor Cells Market Competition, by Players
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells Players Market Share
3.2.2 Top 10 Circulating Tumor Cells Players Market Share
3.3 Market Competition Trend
4 Global Circulating Tumor Cells Market Size by Regions
4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5 North America Circulating Tumor Cells Revenue by Countries
5.1 North America Circulating Tumor Cells Revenue by Countries (2013-2018)
5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6 Europe Circulating Tumor Cells Revenue by Countries
6.1 Europe Circulating Tumor Cells Revenue by Countries (2013-2018)
6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.4 France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Circulating Tumor Cells Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2013-2018)
7.2 China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.5 India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8 South America Circulating Tumor Cells Revenue by Countries
8.1 South America Circulating Tumor Cells Revenue by Countries (2013-2018)
8.2 Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8.3 Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
8.4 Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Circulating Tumor Cells by Countries
9.1 Middle East and Africa Circulating Tumor Cells Revenue by Countries (2013-2018)
9.2 Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.3 UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.4 Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.5 Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
9.6 South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
10 Global Circulating Tumor Cells Market Segment by Type
10.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2013-2018)
10.2 Global Circulating Tumor Cells Market Forecast by Type (2018-2023)
10.3 CTC Enrichment Revenue Growth Rate (2013-2023)
10.4 CTC Detection Revenue Growth Rate (2013-2023)
10.5 CTC Analysis Revenue Growth Rate (2013-2023)
11 Global Circulating Tumor Cells Market Segment by Application
11.1 Global Circulating Tumor Cells Revenue Market Share by Application (2013-2018)
11.2 Circulating Tumor Cells Market Forecast by Application (2018-2023)
11.3 Breast Cancer Revenue Growth (2013-2018)
11.4 Prostate Cancer Revenue Growth (2013-2018)
11.5 Colorectal Cancer Revenue Growth (2013-2018)
11.6 Other Revenue Growth (2013-2018)
12 Global Circulating Tumor Cells Market Size Forecast (2018-2023)
12.1 Global Circulating Tumor Cells Market Size Forecast (2018-2023)
12.2 Global Circulating Tumor Cells Market Forecast by Regions (2018-2023)
12.3 North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.4 Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.6 South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Table
List of Tables and Figures
Figure Circulating Tumor Cells Picture
Table Product Specifications of Circulating Tumor Cells
Table Global Circulating Tumor Cells and Revenue (Million USD) Market Split by Product Type
Figure Global Circulating Tumor Cells Revenue Market Share by Types in 2017
Figure CTC Enrichment Picture
Figure CTC Detection Picture
Figure CTC Analysis Picture
Table Global Circulating Tumor Cells Revenue (Million USD) by Application (2013-2023)
Figure Circulating Tumor Cells Revenue Market Share by Applications in 2017
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Colorectal Cancer Picture
Figure Other Picture
Table Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2013-2023)
Table Menarini-Silicon Biosystems Basic Information, Manufacturing Base and Competitors
Table Menarini-Silicon Biosystems Circulating Tumor Cells Type and Applications
Table Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen?Adnagen? Basic Information, Manufacturing Base and Competitors
Table Qiagen?Adnagen? Circulating Tumor Cells Type and Applications
Table Qiagen?Adnagen? Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Clearbridge Biomedics Basic Information, Manufacturing Base and Competitors
Table Clearbridge Biomedics Circulating Tumor Cells Type and Applications
Table Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Celsee Basic Information, Manufacturing Base and Competitors
Table Celsee Circulating Tumor Cells Type and Applications
Table Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Fluidigm Basic Information, Manufacturing Base and Competitors
Table Fluidigm Circulating Tumor Cells Type and Applications
Table Fluidigm Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ApoCell Basic Information, Manufacturing Base and Competitors
Table ApoCell Circulating Tumor Cells Type and Applications
Table ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Greiner Bio-one GmbH Basic Information, Manufacturing Base and Competitors
Table Greiner Bio-one GmbH Circulating Tumor Cells Type and Applications
Table Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Advanced Cell Diagnostics Basic Information, Manufacturing Base and Competitors
Table Advanced Cell Diagnostics Circulating Tumor Cells Type and Applications
Table Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Aviva Biosciences Basic Information, Manufacturing Base and Competitors
Table Aviva Biosciences Circulating Tumor Cells Type and Applications
Table Aviva Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Fluxion Biosciences Basic Information, Manufacturing Base and Competitors
Table Fluxion Biosciences Circulating Tumor Cells Type and Applications
Table Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table Sysmex Corporation Circulating Tumor Cells Type and Applications
Table Sysmex Corporation Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Epic Sciences Basic Information, Manufacturing Base and Competitors
Table Epic Sciences Circulating Tumor Cells Type and Applications
Table Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Cynvenio Basic Information, Manufacturing Base and Competitors
Table Cynvenio Circulating Tumor Cells Type and Applications
Table Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table CytoTrack Basic Information, Manufacturing Base and Competitors
Table CytoTrack Circulating Tumor Cells Type and Applications
Table CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Ikonisys Basic Information, Manufacturing Base and Competitors
Table Ikonisys Circulating Tumor Cells Type and Applications
Table Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Vortex BioSciences Basic Information, Manufacturing Base and Competitors
Table Vortex BioSciences Circulating Tumor Cells Type and Applications
Table Vortex BioSciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Gilupi Basic Information, Manufacturing Base and Competitors
Table Gilupi Circulating Tumor Cells Type and Applications
Table Gilupi Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Biocept Basic Information, Manufacturing Base and Competitors
Table Biocept Circulating Tumor Cells Type and Applications
Table Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ScreenCell Basic Information, Manufacturing Base and Competitors
Table ScreenCell Circulating Tumor Cells Type and Applications
Table ScreenCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table ANGLE Basic Information, Manufacturing Base and Competitors
Table ANGLE Circulating Tumor Cells Type and Applications
Table ANGLE Circulating Tumor Cells Revenue, Gross Margin and Market Share (2016-2017)
Table Global Circulating Tumor Cells Revenue (Million USD) by Players (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Players (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Players in 2016
Figure Global Circulating Tumor Cells Revenue Share by Players in 2017
Figure Global Top 5 Players Circulating Tumor Cells Revenue Market Share in 2017
Figure Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2017
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Circulating Tumor Cells Revenue (Million USD) by Regions (2013-2018)
Table Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)
Figure Global Circulating Tumor Cells Revenue Market Share by Regions (2013-2018)
Figure Global Circulating Tumor Cells Revenue Market Share by Regions in 2017
Figure North America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Europe Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure South America Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table North America Circulating Tumor Cells Revenue by Countries (2013-2018)
Table North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure North America Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure USA Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Canada Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Mexico Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Europe Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Figure Europe Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Europe Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Germany Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure UK Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure France Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Russia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Italy Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure China Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Japan Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Korea Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure India Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table South America Circulating Tumor Cells Revenue by Countries (2013-2018)
Table South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure South America Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Brazil Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Argentina Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Colombia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Circulating Tumor Cells Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries in 2017
Figure Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure UAE Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Egypt Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure Nigeria Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Figure South Africa Circulating Tumor Cells Revenue and Growth Rate (2013-2018)
Table Global Circulating Tumor Cells Revenue (Million USD) by Type (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Type (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Type (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Type in 2017
Table Global Circulating Tumor Cells Revenue Forecast by Type (2018-2023)
Figure Global Circulating Tumor Cells Market Share Forecast by Type (2018-2023)
Figure Global CTC Enrichment Revenue Growth Rate (2013-2018)
Figure Global CTC Detection Revenue Growth Rate (2013-2018)
Figure Global CTC Analysis Revenue Growth Rate (2013-2018)
Table Global Circulating Tumor Cells Revenue by Application (2013-2018)
Table Global Circulating Tumor Cells Revenue Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Application (2013-2018)
Figure Global Circulating Tumor Cells Revenue Share by Application in 2017
Table Global Circulating Tumor Cells Revenue Forecast by Application (2018-2023)
Figure Global Circulating Tumor Cells Market Share Forecast by Application (2018-2023)
Figure Global Breast Cancer Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Revenue Growth Rate (2013-2018)
Figure Global Colorectal Cancer Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Figure Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Circulating Tumor Cells Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Europe Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure South America Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2018-2023)
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.